Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

National interest may require distributing COVID-19 vaccines to other countries

Tiziano Rotesi, Paolo Pin, Maria Cucciniello, Amyn A. Malik, Elliott E. Paintsil, Scott E. Bokemper, Kathryn Willebrand, Gregory A. Huber, Alessia Melegaro, Saad B. Omer
doi: https://doi.org/10.1101/2021.01.11.21249610
Tiziano Rotesi
1Department of Economics, University of Lausanne, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: tiziano.rotesi@unil.ch
Paolo Pin
2Department of Economics and Statistics, Università di Siena, Italy
3Bocconi Institute for Data Science and Analytics (BIDSA) Bocconi University, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maria Cucciniello
4University of Edinburgh Business School, Scotland, UK
5Dondena Centre for Research in Social Dynamics and Public Policy, Bocconi University Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amyn A. Malik
6Yale Institute for Global Health, New Haven, CT, USA
7Yale School of Medicine, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elliott E. Paintsil
6Yale Institute for Global Health, New Haven, CT, USA
8Colombia University, New York, New York, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Scott E. Bokemper
9Institution for Social and Policy Studies, Yale University, New Haven, CT, USA
10Center for the Study of American Politics, Yale University, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kathryn Willebrand
6Yale Institute for Global Health, New Haven, CT, USA
11Yale School of Public Health, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gregory A. Huber
9Institution for Social and Policy Studies, Yale University, New Haven, CT, USA
10Center for the Study of American Politics, Yale University, New Haven, CT, USA
12Department of Political Science, Yale University, New Haven, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Alessia Melegaro
5Dondena Centre for Research in Social Dynamics and Public Policy, Bocconi University Italy
13Department of Social and Political Sciences Bocconi University Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Saad B. Omer
6Yale Institute for Global Health, New Haven, CT, USA
7Yale School of Medicine, New Haven, CT, USA
8Colombia University, New York, New York, USA
14Yale School of Nursing, Orange, CT, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

As the clinical trials for COVID-19 vaccine progress, understanding how to distribute the initially scarce doses is of paramount importance and a quantitative analysis of the trade-offs involved in domestic-only versus cooperative distribution is still missing. In this study we use a network Susceptible-Infected-Removed (SIR) model to show under which circumstances it is in a country’s self-interest to ensure other countries can also obtain a COVID-19 vaccine rather than focusing only on vaccination of their own residents. In particular, we focus our analysis on the US’s decision and estimate the internal burden of COVID-19 disease under different scenarios about vaccine cooperation. We show that in scenarios in which the US has reached the threshold for domestic herd immunity, the US may find it optimal to donate doses to other countries with lower vaccination coverage, as this would allow for a sharp reduction in the inflow of infected individuals from abroad.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

PP and AM acknowledges support from the Italian Ministry of Education Progetti di Rilevante Interesse Nazionale (PRIN), respectively grant number 2017ELHNNJ and 20177BRJXS. AAM., EL, KW, SO acknowledge support from the Yale Institute for Global Health.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

No human subjects data was used or produced during this research.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Data downloaded from International Civil Aviation Organization cannot be shared, but can be purchased from the provider.

https://doi.org/10.5281/zenodo.4432995

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted January 14, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
National interest may require distributing COVID-19 vaccines to other countries
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
National interest may require distributing COVID-19 vaccines to other countries
Tiziano Rotesi, Paolo Pin, Maria Cucciniello, Amyn A. Malik, Elliott E. Paintsil, Scott E. Bokemper, Kathryn Willebrand, Gregory A. Huber, Alessia Melegaro, Saad B. Omer
medRxiv 2021.01.11.21249610; doi: https://doi.org/10.1101/2021.01.11.21249610
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
National interest may require distributing COVID-19 vaccines to other countries
Tiziano Rotesi, Paolo Pin, Maria Cucciniello, Amyn A. Malik, Elliott E. Paintsil, Scott E. Bokemper, Kathryn Willebrand, Gregory A. Huber, Alessia Melegaro, Saad B. Omer
medRxiv 2021.01.11.21249610; doi: https://doi.org/10.1101/2021.01.11.21249610

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (168)
  • Anesthesia (49)
  • Cardiovascular Medicine (448)
  • Dentistry and Oral Medicine (80)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (190)
  • Epidemiology (5216)
  • Forensic Medicine (3)
  • Gastroenterology (194)
  • Genetic and Genomic Medicine (750)
  • Geriatric Medicine (77)
  • Health Economics (212)
  • Health Informatics (694)
  • Health Policy (352)
  • Health Systems and Quality Improvement (223)
  • Hematology (98)
  • HIV/AIDS (162)
  • Infectious Diseases (except HIV/AIDS) (5816)
  • Intensive Care and Critical Care Medicine (356)
  • Medical Education (102)
  • Medical Ethics (25)
  • Nephrology (80)
  • Neurology (758)
  • Nursing (43)
  • Nutrition (129)
  • Obstetrics and Gynecology (141)
  • Occupational and Environmental Health (231)
  • Oncology (475)
  • Ophthalmology (149)
  • Orthopedics (38)
  • Otolaryngology (93)
  • Pain Medicine (39)
  • Palliative Medicine (19)
  • Pathology (139)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (136)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (854)
  • Public and Global Health (1993)
  • Radiology and Imaging (344)
  • Rehabilitation Medicine and Physical Therapy (157)
  • Respiratory Medicine (283)
  • Rheumatology (93)
  • Sexual and Reproductive Health (72)
  • Sports Medicine (75)
  • Surgery (108)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)